Previously known as Nirvation, NiRACLE, LLC was founded in 2009 by Dr. Weiyong Li who has more than 20 years of experience in formulation an PAT technology, especially using Near Infrared as tool. After partnering with more scientific and business talents, Nirvation became NiRACLE in 2011.

NiRACLE has a wide range of experience in pre-formulation and formulation development. We have pioneered “Supervised Principle Component” (SPC) technology (US Patent No. 2011 / 0216313 A1). Our services include but not limited to:

Late-stage pharmaceutical product development including characterization, control of fluid-bed wet granulation process, establishment of correlations between formulation/process parameters and product quality attributes
Development and implementation of multivariate data analysis approach to help define the quality-by-design process control strategies in formulation development and pharmaceutical manufacturing
Study of drug release mechanism from matrix based prolonged release tablets to help expand formulation development capability of the department
Online NIR probe for monitor pharmaceutical blend uniformity
Development of a novel approach for creation of NIR calibration models that can be implemented in early and late stage tablet formulation development for assessment of content uniformity
Implementation of NIR methods for commerical products to reduce testing cost and improve quality
Training of lab chemists in NIR, NIR chemical imaging and multivariate modeling

NiRACLE maintains strict confidentiality to our client’s product R&D programs. Our capability will increase the probability of achieving your next key milestones (new drug product approving). We understand exactly what your need and requirements are. Our scientists are motive to provide you highest levels of scientific expertise. Together as a team, we work closely with our client to demonstrate high quality and best possible results, project by project, client by client.

Niracle, LLC. training

Training